Clinical trial Recruiting at 5 sites Observational Ages 18 and up

Genetic testing for hereditary cancer in Switzerland

Official title: Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland

Run by University of Basel · NCT03124212 · Data updated 2026-11-12

This study is trying to see if testing family members of people with hereditary breast, ovarian cancer, or Lynch syndrome can help identify those at risk and improve their chances of early detection and management.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment700 (estimated)
SponsorUniversity of Basel
Academic / other
Locations9 sites (Fribourg, Canton of Fribourg and 8 other locations)
StatusRecruiting
StartedApril 1, 2017
Main results expectedJanuary 31, 2035
Study endsJanuary 31, 2035
Registry record updatedMay 13, 2026
Trial IDNCT03124212 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals who are known mutation carriers of HBOC or LS and have at least one living blood relative.

Probably not a fit

Patients who are critically ill, institutionalized, or living outside of Switzerland may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on cascade genetic testing for hereditary breast and ovarian cancer (HBOC) and Lynch syndrome (LS) in Switzerland. It aims to identify and test family members of known mutation carriers to determine if they are also carriers of genetic mutations associated with these cancers. By improving access to genetic counseling and testing, the study seeks to enhance early detection and management of cancer risks among asymptomatic relatives. The methodology involves a coordinated approach to genetic screening and communication among family members.

Why it matters

Potential benefit: If successful, this study could significantly reduce cancer mortality through early identification and management of hereditary cancer risks.

How similar studies have gone: Other studies have shown success with similar cascade screening approaches, indicating potential effectiveness in improving genetic testing uptake.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Carrier of a mutation associated with HBOC or LS
2. Have at least one living blood relative
3. Men and women
4. 18 years old and older
5. Mentally and physically able to provide informed consent
6. Can read and speak German or French or Italian or English
7. Currently living in Switzerland.

Exclusion Criteria:

1. Carriers of unclassified variants (VUS) in BRCA1, BRCA2 or MLH1, MSH2, MSH6, PMS2, EPCAM genes
2. Not living in Switzerland
3. Patients who are critically ill and cannot complete the CASCADE survey
4. Participants who are institutionalized (e.g., nursing homes) or incarcerated

Where it's running

  • Hôpital du Jura Service d'Oncologie
    Delémont, Canton of Jura, Switzerland
    Recruiting
  • University Hospital Basel
    Basel, Switzerland
    Recruiting
  • Istituto Oncologico della Zvizzera Italiana
    Bellinzona, Switzerland
    Recruiting
  • Universitatklinik fur Medizinische Onkologie, Inselspital
    Bern, Switzerland
    Recruiting
  • Unite d'Oncogenetique et de Prevention des Cancers
    Geneva, Switzerland
    Recruiting
  • HFR Fribourg - Hôpital Cantonal
    Fribourg, Canton of Fribourg, Switzerland
    Not yet recruiting
Show 3 more locations
  • Hirslanden Clinic Des Grangettes
    Geneva, Canton of Geneva, Switzerland
    Not yet recruiting
  • Katonsspital Winterthur Tumorzentrum Brustzentrum
    Winterthur, Canton of Zurich, Switzerland
    Not yet recruiting
  • Gastroenterology clinic
    Bern, Switzerland
    Terminated

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.